Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huaming Tan

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Oral Oncology|September 23, 2008
Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: to what extent the volume should be irradiatedHeming Lu, Min Yao, Huaming Tan
Statistics in Medicine|June 30, 2011
A case study of model-based Bayesian dose response estimationHuaming Tan, David Gruben, Jonathan French, et al.
Journal of Clinical Pharmacology|May 21, 2020
Predictors of Systemic Exposure to Topical Crisaborole: A Nonlinear Regression AnalysisVivek Purohit, Steve Riley, Huaming Tan, et al.
Statistics in Medicine|August 14, 2025
Cumulative Logit Ordinal Regression With Proportional Odds Under Nonignorable Missing Responses-Application to Phase III TrialArnab Kumar Maity, Huaming Tan, Vivek Pradhan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 21, 2025
Clinical Efficacy and Safety of Cadonilimab Immunotherapy in Advanced Cervical Cancer: A Retrospective StudyXiuchen Han, Minjie Fang, Huaming Tan, et al.
Journal of Drugs in Dermatology : JDD|March 6, 2014
Efficacy of tofacitinib, an oral janus kinase inhibitor, on clinical signs of moderate-to-severe plaque psoriasis in different body regionsAlan Menter, Kim A Papp, Huaming Tan, et al.
Dermatology and Therapy|December 2, 2016
Under-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan DataApril W Armstrong, J Will Koning, Simon Rowse, et al.
Clinical Drug Investigation|March 18, 2017
Initiation, Switching, and Cessation of Psoriasis Treatments Among Patients with Moderate to Severe Psoriasis in the United StatesApril W Armstrong, J Will Koning, Simon Rowse, et al.
Frontiers in Oncology|May 20, 2024
Myelopreservation with Trilaciclib in recurrent advanced ovarian cancer: a case reportHuaming Tan, Xiuchen Han, Chao Li, et al.
Journal of Drugs in Dermatology : JDD|August 13, 2015
Randomized Pilot Clinical Trial of Tofacitinib Solution for Plaque Psoriasis: Challenges of the Intra-Subject Study DesignWilliam C Ports, Steven R Feldman, Pankaj Gupta, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Oral Oncology|September 23, 2008
Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: to what extent the volume should be irradiatedHeming Lu, Min Yao, Huaming Tan
Statistics in Medicine|June 30, 2011
A case study of model-based Bayesian dose response estimationHuaming Tan, David Gruben, Jonathan French, et al.
Journal of Clinical Pharmacology|May 21, 2020
Predictors of Systemic Exposure to Topical Crisaborole: A Nonlinear Regression AnalysisVivek Purohit, Steve Riley, Huaming Tan, et al.
Statistics in Medicine|August 14, 2025
Cumulative Logit Ordinal Regression With Proportional Odds Under Nonignorable Missing Responses-Application to Phase III TrialArnab Kumar Maity, Huaming Tan, Vivek Pradhan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 21, 2025
Clinical Efficacy and Safety of Cadonilimab Immunotherapy in Advanced Cervical Cancer: A Retrospective StudyXiuchen Han, Minjie Fang, Huaming Tan, et al.
Journal of Drugs in Dermatology : JDD|March 6, 2014
Efficacy of tofacitinib, an oral janus kinase inhibitor, on clinical signs of moderate-to-severe plaque psoriasis in different body regionsAlan Menter, Kim A Papp, Huaming Tan, et al.
Dermatology and Therapy|December 2, 2016
Under-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan DataApril W Armstrong, J Will Koning, Simon Rowse, et al.
Clinical Drug Investigation|March 18, 2017
Initiation, Switching, and Cessation of Psoriasis Treatments Among Patients with Moderate to Severe Psoriasis in the United StatesApril W Armstrong, J Will Koning, Simon Rowse, et al.
Frontiers in Oncology|May 20, 2024
Myelopreservation with Trilaciclib in recurrent advanced ovarian cancer: a case reportHuaming Tan, Xiuchen Han, Chao Li, et al.
Journal of Drugs in Dermatology : JDD|August 13, 2015
Randomized Pilot Clinical Trial of Tofacitinib Solution for Plaque Psoriasis: Challenges of the Intra-Subject Study DesignWilliam C Ports, Steven R Feldman, Pankaj Gupta, et al.
Pageof 4